Patents Examined by Janet Epps-Smith
  • Patent number: 9023384
    Abstract: It is intended to efficiently inject into a target cell, a substance charged within a liposome. The present inventors have found that connexin synthesized within a liposome is introduced as connexon having a gap junction function into the liposome membrane. Specifically, the liposome according to the present invention is a liposome in which connexon composed of connexin synthesized by an in-vitro protein synthesis system is incorporated in a state of having a gap junction function.
    Type: Grant
    Filed: November 2, 2005
    Date of Patent: May 5, 2015
    Assignees: Tokyo Medical and Dental University, Dai Nippon Printing Co., Ltd.
    Inventors: Ikuo Morita, Kazunari Akiyoshi, Shinichiro Nomura
  • Patent number: 9023370
    Abstract: The present invention relates to conjugates of formula (I) having colloidal stability in a medium, wherein NP is a gold, silver or platinum nanoparticle; L is a linker selected from the group consisting of formula (II), formula (III), and a stereoisomer of any of the formulas (II) and (III), which is attached to the nanoparticle NP through sulfur atoms; wherein the meanings of X, n, p, Y and s are further specified in the description; and A is a platinum (II) biradical selected from the group consisting of formula (IV), formula (V) and formula (VI) including any of the stereoisomers of all of them, wherein the biradical is optionally in the form of a salt and is attached to the linker L through the single bonded oxygen atoms of the carboxyl groups. It also relates to a process for the preparation of the conjugates of formula (I) and to pharmaceutical compositions containing them. The conjugates of the invention are used for the treatment of cancer.
    Type: Grant
    Filed: December 15, 2009
    Date of Patent: May 5, 2015
    Assignees: Fundacio Privada Institut Catala de Nanotecnologia, Institucio Catalana de Recerca I Estudis Avancats, Universidade de Santiago de Compostela, Universitat de Valencia, Fundacio Institut de Recerca de l'Hospital de la Santa Creu J Sant Pau
    Inventors: Victor Franco Puntes, Fernando Domíguez Puente, Francisco Manuel Romero Martínez, Óscar Gallego Rubio
  • Patent number: 9018135
    Abstract: A pesticidal composition comprising (a) a pesticidal effective amount of at least one compound of formula I in which Q is i or ii or iii or an agrochemically acceptable salt or an N-oxide thereof, and (b) a plant growth regulator, where the ratio of compound of formula I to plant growth regulator is from 20:1 to 1:25.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: April 28, 2015
    Assignee: Syngenta Participations AG
    Inventors: Anke Buchholz, Werner Reiner
  • Patent number: 9018235
    Abstract: Insecticide compositions which comprise one or not less than two kinds of compounds being selected from a compound represented by the formula [I]: or a salt thereof, and a neonicotinoid compound represented by the formula [II]: The insecticide compositions can produce higher insecticidal effects than would be expected when each of the active ingredients is used singly, namely a synergistic effect, thus enabling reductions in the rate or number of application of agrochemicals and pesticides to be realized.
    Type: Grant
    Filed: May 27, 2010
    Date of Patent: April 28, 2015
    Assignee: Sumitomo Chemical Company, Limited
    Inventor: Yuichi Ohkawara
  • Patent number: 9011855
    Abstract: The present weed reducing material reduces the necessary weed control work by making joint filling sand a hostile substrate for plant and fungus growth by using an environmentally acceptable slow release mineral additive. The additive, having similar grain size distribution, mechanical and rheological properties, forms an integral part of the joint filling sand. The specific gravity of the additive is lower than quartz sand imparting a tendency for the additive to migrate towards the top part of the joint. The additive leads to pore waters rich in sodium and at high pH, both qualities being maintained over long periods. The mixture of additive and sand is handled and applied using conventional laying techniques and equipment, observing usual precautions for mortar or cement mixes with sand. In the environment, reaction with CO2 in the air or in the soil porosity inactivates the causticity, yielding harmless carbonate salts.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: April 21, 2015
    Inventors: Jens Sønderberg Frederiksen, Poul Konrad Beck, Steffen Birk Hvorslev
  • Patent number: 9012225
    Abstract: Disclosed are lipophilic polynucleotide conjugates including polynucleotide-cholesterol conjugates and methods of delivering therapeutic polynucleotides to a mammalian cell or patient in need of treatment using said conjugates. The disclosure further provides methods of synthesizing the lipophilic polynucleotide conjugates. The conjugates are designed to mimic or target cellular miRNAs. The lipophilic moiety, such as cholesterol or cholesterol derivative, is spaced from the polynucleotide by a substantially linear hydrocarbon group. Due to an absence of significantly polar groups and/or exchangeable protons in the vicinity of the lipophilic moiety, the interaction between the lipophilic moiety and cell membranes is enhanced to provide for efficient entry into cells.
    Type: Grant
    Filed: May 5, 2010
    Date of Patent: April 21, 2015
    Assignee: miRagen Therapeutics
    Inventors: Kurt Vagle, William S. Marshall
  • Patent number: 9005638
    Abstract: This invention provides cosmetics containing a multi-functional composite powder having the properties of (a) an excellent adhesiveness, (b) an excellent extendability, (c) an appropriate glossy effect, (d) a homogeneous cosmetic film, (e) an appropriate covering capability, (f) a cosmetic film not causing a white masking, (g) a high compatibility between a color appearance of cosmetics and a color tone of the cosmetic film, (h) an excellent soft-focusing capability, (i) an excellent ultraviolet protective effect, and the like. The multi-functional composite powder is constituted by a scale-like base material, a group of particles comprising at least fine particles of titanium dioxide deposited on a surface of the scale-like base material, and a thin film of a composite oxide containing titanium and iron coated thereon.
    Type: Grant
    Filed: July 31, 2007
    Date of Patent: April 14, 2015
    Assignee: JGC Catalysts and Chemicals Ltd.
    Inventors: Shuji Matsumoto, Naoyuki Enomoto, Yasutaka Miyoshi, Takumi Miyazaki
  • Patent number: 9005972
    Abstract: Provided herein is an apparatus for printing cells which includes an electrospinning device and an inkjet printing device operatively associated therewith. Methods of making a biodegradable scaffold having cells seeded therein are also provided. Methods of forming microparticles containing one or more cells encapsulated by a substrate are also provided, as are methods of forming an array of said microparticles.
    Type: Grant
    Filed: February 20, 2014
    Date of Patent: April 14, 2015
    Assignee: Wake Forest University Health Sciences
    Inventors: Tao Xu, James J. Yoo, Anthony Atala, Dennis Dice
  • Patent number: 9006212
    Abstract: Provided herein are compositions and kits comprising carbohydrate-based inhibitors that bind GNBP and/or inhibit ?(1,3)-glucanase activity. Also provided are methods of using such inhibitors to protect against or treat pest infestation, as are compositions and kits comprising subparts of the carbohydrate-based inhibitors.
    Type: Grant
    Filed: May 11, 2010
    Date of Patent: April 14, 2015
    Assignees: Massachusetts Institute of Technology, Northeastern University
    Inventors: Ido Bachelet, Ram Sasisekharan, Mark Bulmer, Rebeca B. Rosengaus
  • Patent number: 8999345
    Abstract: The disclosure provides adjuvants, immunogenic compositions, and methods useful for vaccination and immune response. In particular, the disclosure provides a class of adjuvants comprising cationic lipid:co-lipid mixtures and methods for delivering formulated compositions.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: April 7, 2015
    Assignee: Vical Incorporated
    Inventors: Jukka Hartikka, Sean M. Sullivan, Joel D. Enas, Alain Rolland
  • Patent number: 8993316
    Abstract: A composition and method comprising an anti-adjuvant such as DOI (an anti-inflammatory) together with any gene therapy plasmid is disclosed. A method for GHRH production in-vivo using a set of compositions and methods for use of those compositions is provided.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: March 31, 2015
    Inventor: Brian P. Hanley
  • Patent number: 8993480
    Abstract: Agrochemical compositions comprising at least one active compound from the class of the anthranilamides and at least one further active compound selected from the group consisting of insecticides, fungicides, and/or acaricides have excellent synergistic activity.
    Type: Grant
    Filed: April 2, 2012
    Date of Patent: March 31, 2015
    Assignee: Bayer CropScience AG
    Inventors: Christian Funke, Rüdiger Fischer, Reiner Fischer, Wolfgang Thielert, Anton Kraus, Heike Hungenberg
  • Patent number: 8974803
    Abstract: Injectable biomaterial compositions formed from tropoelastin for tissue repair and restoration. The compositions include a coalescence-controlling agent in the form of a polysaccharide or polysaccharide derivative, in an amount effective for providing the substance with the properties of flow, enabling injection.
    Type: Grant
    Filed: March 10, 2010
    Date of Patent: March 10, 2015
    Assignee: The University of Sydney
    Inventors: Anthony Steven Weiss, Suzanne Marie Mithieux
  • Patent number: 8974363
    Abstract: New photodynamic, topically-applicable medicaments and certain medical uses of such photodynamic medicaments for treatment of human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene. The halogenated xanthenes constitute a family of potent photosensitizers that become photoactivated upon illumination of the treatment site with visible wavelengths of light. In preferred embodiments, such medicaments are used for treatment of a variety of conditions affecting the skin and related organs; the mouth and digestive tract and related organs; the urinary and reproductive tracts and related organs; the respiratory tract and related organs; various other internal or external tissue surfaces, such as tissue surfaces exposed during surgery; and for treatment of a variety of conditions related to microbial or parasitic infection.
    Type: Grant
    Filed: November 8, 2007
    Date of Patent: March 10, 2015
    Assignee: Provectus Pharmatech, Inc.
    Inventors: H. Craig Dees, Timothy C. Scott, John Smolik, Eric A. Wachter, Walter G. Fisher
  • Patent number: 8975079
    Abstract: Provided herein are biodegradable copolymers and nanoplex delivery systems comprising the same and a cargo molecule, such as a nucleic acid, a polynucleotide or other biomolecule. The biodegradable copolymers may comprise a reducible polymer linearly modified with lysine, such as a linear lysine-modified N,N?-cystamine bisacrylamide. The biodegradable copolymers also may be conjugated to a sequestering moiety, such as dietheylamine. The biodegradable copolymers also may comprise one or both of a targeting moiety and one or more moieties to facilitate endosomal escape. Also provided are methods for treating a pathophysiological condition and for increasing biocompatibility of a polymeric delivery system upon delivery to a subject using the biodegradable copolymers and nanoplexes.
    Type: Grant
    Filed: February 11, 2010
    Date of Patent: March 10, 2015
    Assignee: University of Houston System
    Inventor: Malavosklish Bikram
  • Patent number: 8969080
    Abstract: Disclosed is the use of inhibitors of ?-catenin expression or activity or modulators downregulating ?-catenin expression or activity for the treatment of cardiovascular diseases or disorders and their use in the treatment of cardiovascular diseases and disorders, such as heart failure syndrome. The use of those agents resulted in particular in cardiomyocyte differentiation of endogenous cardiac stem cells.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: March 3, 2015
    Assignee: Max-Delbrueck-Centrum fuer Molekulare Medizin
    Inventors: Martin Bergmann, Joerg Huelsken, Walter Birchmeier, Makoto Mark Taketo
  • Patent number: 8946127
    Abstract: Use of the ssrA gene or tmRNA, an RNA transcript of the ssrA gene, or fragments thereof as target regions in a nucleic acid probe assay for the detection and identification of prokaryotic and/or eukaryotic organisms is described. Nucleotide sequence alignment of tmRNA sequences from various organisms can be used to identify regions of homology and non-homology within the sequences which in turn can be used to design both genus specific and species specific oligonucleotide probes. These newly identified regions of homology and non-homology provide the basis of identifying and detecting organisms at the molecular level. Oligonucleotide probes identified in this way can be used to detect tmRNA in samples thereby giving an indication of the viability of non-viral organisms present in various sample types.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: February 3, 2015
    Assignees: Enterprise Ireland, National University of Ireland
    Inventors: Thomas Gerard Barry, Terence James Smith
  • Patent number: 8946123
    Abstract: Described herein are compositions including an herbicide, a capsaicinoid, and an acrylic for controlling the direction of growth of plants with rootlets. Also described herein are methods for making and using the compositions.
    Type: Grant
    Filed: May 27, 2009
    Date of Patent: February 3, 2015
    Inventor: Richard Foster Debutts
  • Patent number: 8937177
    Abstract: The present invention relates to pyridazine compounds of formulae I or II and the salts and N-oxides thereof, wherein the substituents are as defined in the description, a method for controlling invertebrate pests, to a method for protecting plant propagation material and/or the plants which grow therefrom, to plant propagation material, comprising at least one compound according to the present invention, to a method for treating or protecting an animal from infestation or infection by parasites and to an agricultural composition containing at least one compound according to the present invention.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: January 20, 2015
    Assignee: BASF SE
    Inventors: Ronan Le Vezouet, Sebastian Soergel, Christian Defieber, Steffen Gross, Karsten Koerber, Douglas D. Anspaugh, Deborah L. Culbertson
  • Patent number: 8936942
    Abstract: The present invention provides compositions comprising polytheylyene-dialkyloxypropyl conjugates (PEG-DAA), liposomes, SNALP, and SPLP comprising such compositions, and methods of using such compositions, liposomes, SNALP, and SPLP.
    Type: Grant
    Filed: August 6, 2010
    Date of Patent: January 20, 2015
    Assignee: Protiva Biotherapeutics, Inc.
    Inventors: James Heyes, Ian MacLachlan, Ellen Grace Ambegia